Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Diabetes

  Free Subscription


Articles published in Eur J Endocrinol

Retrieve available abstracts of 22 articles:
HTML format



Single Articles


    August 2025
  1. HAN AJ, Achenbach SJ, Atkinson EJ, Bancos I, et al
    Identifying factors associated with subsequent diagnosis of adrenal adenoma: a population-based historical case-control study.
    Eur J Endocrinol. 2025;193:383-390.
    PubMed     Abstract available


  2. LAVER TW, Patel KA
    MODY and Beyond: The Changing Face of Single-Gene Diabetes.
    Eur J Endocrinol. 2025 Aug 16:lvaf172. doi: 10.1093.
    PubMed     Abstract available


    June 2025
  3. WYCKOFF JA, Lapolla A, Asias-Dinh BD, Barbour LA, et al
    Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.
    Eur J Endocrinol. 2025;193:G1-G48.
    PubMed     Abstract available


    May 2025
  4. SHAPIRO ALB, Narongkiatikhun P, Choi YJ, Wilkening G, et al
    Altered brain function and structure in youth-onset type 2 diabetes.
    Eur J Endocrinol. 2025 May 8:lvaf098. doi: 10.1093.
    PubMed     Abstract available


    April 2025
  5. ZHANG M, Ward J, Strawbridge RJ, Anderson JJ, et al
    Genetic predisposition to adiposity, and type 2 diabetes: the role of lifestyle and phenotypic adiposity.
    Eur J Endocrinol. 2025;192:549-557.
    PubMed     Abstract available


  6. FEOLA T, De Alcubierre D, Puliani G, Cozzolino A, et al
    Circulating immune cell profile in patients with acromegaly: results from the PROMISE, a prospective clinical trial.
    Eur J Endocrinol. 2025;192:577-589.
    PubMed     Abstract available


    March 2025
  7. GLINTBORG D, Moller JK, Rubin KH, Christensen LL, et al
    Autoimmune diseases in 3812 Danish transgender persons and 38 120 cisgender controls before and after transgender care: a register-based cohort study.
    Eur J Endocrinol. 2025;192:408-417.
    PubMed     Abstract available


  8. MENSBERG P, Frandsen C, Carl CS, Espersen E, et al
    High-intensity interval training improves insulin sensitivity in individuals with prediabetes.
    Eur J Endocrinol. 2025;192:456-465.
    PubMed     Abstract available


  9. STERGIANOS S, Everhov AH, Soderling J, Bergthorsdottir R, et al
    Income and work loss in patients with Addison's disease: a nationwide population-based study.
    Eur J Endocrinol. 2025;192:170-179.
    PubMed     Abstract available


  10. GAMBINERI A, Rosa S, Pandurevic S, Cecchetti C, et al
    Evolution of cardiovascular risk factors and the risk for cardiovascular events in a Caucasian population with polycystic ovary syndrome.
    Eur J Endocrinol. 2025;192:210-219.
    PubMed     Abstract available


    February 2025
  11. OLLILA MM, Hautakoski A, Arffman M, Morin-Papunen L, et al
    Diabetic complications in women with type 2 diabetes and polycystic ovary syndrome.
    Eur J Endocrinol. 2025 Feb 21:lvaf026. doi: 10.1093.
    PubMed     Abstract available


    December 2024
  12. ROBLEDO KP, Marschner IC, Grossmann M, Handelsman DJ, et al
    Predicting Type 2 Diabetes and Testosterone Effects in high-risk Australian men: Development and external validation of a 2 year risk model.
    Eur J Endocrinol. 2024 Dec 25:lvae166. doi: 10.1093.
    PubMed     Abstract available


    October 2024
  13. LUNDQVIST MH, Pereira MJ, Wiklund U, Hetty S, et al
    Autonomic nervous system responses to hypo- and hyperglycemia in type 2 diabetes and prediabetes.
    Eur J Endocrinol. 2024 Oct 26:lvae130. doi: 10.1093.
    PubMed     Abstract available


    July 2024
  14. HANSEN LS, Gasbjerg LS, Bronden A, Dalsgaard NB, et al
    The role of glucagon-like peptide 1 in the postprandial effects of metformin in type 2 diabetes: a randomized crossover trial.
    Eur J Endocrinol. 2024 Jul 25:lvae095. doi: 10.1093.
    PubMed     Abstract available


  15. FOUNTAS A, Coulden A, Fernandez-Garcia S, Tsermoulas G, et al
    Central diabetes insipidus (vasopressin deficiency) after surgery for pituitary tumours: A systematic review and meta-analysis.
    Eur J Endocrinol. 2024 Jul 12:lvae084. doi: 10.1093.
    PubMed     Abstract available


  16. ONO M, Nagao M, Takeuchi H, Fukunaga E, et al
    HLA investigation in ICI-induced T1D and isolated ACTH deficiency including meta-analysis.
    Eur J Endocrinol. 2024;191:9-16.
    PubMed     Abstract available


  17. GROSSMANN M, Anawalt BD, Yeap BB
    Testosterone therapy in older men: clinical implications of recent landmark trials.
    Eur J Endocrinol. 2024;191:R22-R31.
    PubMed     Abstract available


    June 2024
  18. RIX I, Lund AB, Garvey LF, Hansen CP, et al
    Increased hepatic glucagon sensitivity in totally pancreatectomised patients.
    Eur J Endocrinol. 2024;190:446-457.
    PubMed     Abstract available


    April 2024
  19. FUHRI SNETHLAGE CM, Meijnikman AS, Mak AL, Rampanelli E, et al
    Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetes.
    Eur J Endocrinol. 2024 Apr 29:lvae043. doi: 10.1093.
    PubMed     Abstract available


    March 2024
  20. GETHER IM, Bahne E, Nerild HH, Rehfeld JF, et al
    Colesevelam has no acute effect on postprandial GLP-1 levels but abolishes gallbladder refilling.
    Eur J Endocrinol. 2024;190:314-326.
    PubMed     Abstract available


  21. ATILA C, Beck J, Refardt J, Erlic Z, et al
    Psychopathological characteristics in patients with arginine vasopressin deficiency (central diabetes insipidus) and primary polydipsia compared to healthy controls.
    Eur J Endocrinol. 2024 Mar 29:lvae040. doi: 10.1093.
    PubMed     Abstract available


  22. AHN HY, Lee J, Kang J, Lee EK, et al
    Increased risk of diabetes mellitus and hyperlipidemia in patients with differentiated thyroid cancer.
    Eur J Endocrinol. 2024;190:248-255.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.